Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offerings. SVB Financial Group executed its offerings of $500 million aggregate principal...
SVB Financial’s $1.5 Billion Notes and Preferred Stock Offerings
ImmunityBio’s $500 Million At-the-Market Offering
Davis Polk advised the sales agent on the offering. ImmunityBio, Inc. executed an at-the-market offering of its common stock for up to an aggregate amount of $500 million....
ImmunityBio’s $500 Million At-the-Market Offering
Davis Polk advised the sales agent on the offering. ImmunityBio, Inc. executed an at-the-market offering of its common stock for up to an aggregate amount of $500 million....
EDAP TMS’s $28 Million Public Offering
Davis Polk advised the underwriters in the offering, while Jones Day advised EDAP. EDAP TMS S.A. executed its $28 million public offering of 4,150,000 American depositary shares,...
NeuroPace’s $102 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. NeuroPace, Inc. executed its initial public offering of 6,900,000 shares of common stock at...
UiPath’s $1.54 Billion Initial Public Offering
Davis Polk advised the representatives of the several underwriters on the deal while Cooley LLP represented UiPath. UiPath, Inc. executed its $1.54 billion initial public offering of...
Recursion Pharmaceuticals’ $500 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. Recursion Pharmaceuticals, Inc. executed its $500 million initial public offering of 27,878,787 shares of Class...
Ultra Clean’s $175 Million Follow-on Offering
Davis Polk advised Ultra Clean Holdings on the deal. Ultra Clean Holdings, Inc. executed its SEC-registered follow-on public offering of 3,181,818 shares of common stock for...
Alkami Technology’s $180 Million Initial Public Offering
Latham & Watkins LLP represented Alkami in the offering, Davis Polk advised the representatives of the several underwriters. Alkami Technology, Inc., a leading cloud-based digital banking...
Ionis Pharmaceuticals’ $632.5 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the several purchasers in offering. Ionis Pharmaceuticals, Inc. executed its offering of an aggregate principal amount of $632.5 million of its...
Maravai LifeSciences’s $646.9 Million Secondary Offering
Davis Polk advised the joint book-running managers in the offering. The $646.9 million secondary offering of 20,700,000 shares of common stock of Maravai LifeSciences Holdings, Inc....
Marvell Technology’s $2 Billion Senior Notes Offering
Davis Polk advised the initial purchasers in the offering. The $2 billion in aggregate principal amount of senior notes issued by Marvell Technology, Inc., a wholly owned...